Interleukin 6 is expressed in high levels in psoriatic skin and stimulates proliferation of cultured human keratinocytes. - Wikidata - awgldk - TriplyDB

Interleukin 6 is expressed in high levels in psoriatic skin and stimulates proliferation of cultured human keratinocytes.

Interleukin 6 is expressed in high levels in psoriatic skin and stimulates proliferation of cultured human keratinocytes.

http://www.wikidata.org/entity/Q34298307

about

Regulation generation: the suppressive functions of human regulatory T cells Interleukin-6 blockade in ocular inflammatory diseases Roles of keratinocyte inflammation in oral cancer: regulating the prostaglandin E2, interleukin-6 and TNF-alpha production of oral epithelial cells by areca nut extract and arecoline 12(S)-Hydroxyheptadeca-5Z,8E,10E-trienoic acid suppresses UV-induced IL-6 synthesis in keratinocytes, exerting an anti-inflammatory activity Epithelial antimicrobial peptides: review and significance for oral applications Repression of the interleukin 6 gene promoter by p53 and the retinoblastoma susceptibility gene product Wound healing revised: a novel reepithelialization mechanism revealed by in vitro and in silico models.The role of interleukin-6 (IL-6) in human sulfur mustard (HD) toxicology.New drugs in the treatment of psoriasis.Functional hyper-IL-6 from vaccinia virus-colonized tumors triggers platelet formation and helps to alleviate toxicity of mitomycin C enhanced virus therapy Cytokines in psoriasis.Characterization of a human skin equivalent model to study the effects of ultraviolet B radiation on keratinocytes.Helicobacter pylori CagA phosphorylation status determines the gp130-activated SHP2/ERK and JAK/STAT signal transduction pathways in gastric epithelial cells.Interleukin-11 therapy selectively downregulates type I cytokine proinflammatory pathways in psoriasis lesions.Filaggrin-deficient mice exhibit TH17-dominated skin inflammation and permissiveness to epicutaneous sensitization with protein antigen IL-6 signaling in psoriasis prevents immune suppression by regulatory T cells.IL-6 as a druggable target in psoriasis: focus on pustular variants.Anti-interleukin 6 receptor antibody treatment in rheumatic disease.Biological products for the treatment of psoriasis: therapeutic targets, pharmacodynamics and disease-drug-drug interaction implications Pathogenic mechanisms shared between psoriasis and cardiovascular disease Inhibition of TYK2 and JAK1 ameliorates imiquimod-induced psoriasis-like dermatitis by inhibiting IL-22 and the IL-23/IL-17 axis.Dynamics of the cellular and humoral components of the inflammatory response elicited in skin blisters in humans.IL-6 in inflammation, immunity, and disease Amniotic fluid interleukin 6 in preterm labor. Association with infection.Dysregulated interleukin 6 expression produces a syndrome resembling Castleman's disease in mice.Pathogenetic factors in Sjögren's syndrome: recent developments.Sleep loss and cytokines levels in an experimental model of psoriasis.Muramyl dipeptide induces Th17 polarization through activation of endothelial cells.Cytokine profiles of filarial granulomas in jirds infected with Brugia pahangi.The paradigm of IL-6: from basic science to medicine Role of chemically induced cell proliferation in carcinogenesis and its use in health risk assessment Interleukin 6 and 8 levels in plasma and fibroblast cultures in psoriasis.Molecular cross-talk between the NFkappaB and STAT3 signaling pathways in head and neck squamous cell carcinoma Luteolin inhibits human keratinocyte activation and decreases NF-κB induction that is increased in psoriatic skin.Clinical research helps elucidate the role of tumor necrosis factor-alpha in the pathogenesis of T1-mediated immune disorders: use of targeted immunotherapeutics as pathogenic probes.Tumour necrosis factor alpha impairs function of liver derived T lymphocytes and natural killer cells in patients with primary sclerosing cholangitis.Role of monocytes in atherogenesis.Keratinocyte proinflammatory responses to adherent and nonadherent group A streptococci.Cutaneous barrier perturbation stimulates cytokine production in the epidermis of mice.Interleukin-1 receptor antagonist in normal and psoriatic epidermis.

P2860

Q26823216-30172D03-BF66-43A1-9954-B115E191D11D Q27011357-FC37BD0C-0374-4CCE-9B00-1F2B457CA941 Q28196459-F8ECAB32-C552-4F28-ADF3-94D77C588AB4 Q28261286-85EB5AD5-62A6-428B-98C0-ED179225845B Q28289518-DFC4B3E7-1725-4FF1-AB42-1976CB043306 Q28645822-997D2E6E-6050-446D-AC1E-F94446E83374 Q30557891-AA6B7083-E076-4923-B3F5-6C4C3D784E00 Q32053147-6C286BC6-5A0E-4722-A66A-436D3BE98728 Q33181382-A7319B8E-226A-490C-A92C-E532F9D99493 Q33399140-3E3A6F11-1674-495F-886F-75231FCFA875 Q33632263-54451E13-59F0-43C7-B962-384551A42D06 Q33820095-38CE6DC9-B823-430A-9148-F403F8EC779B Q33855205-EA17E757-19AB-4383-A41B-E7F300F596D2 Q33902313-5E2BAD1B-9E7C-4901-AA74-5C46A1FE2D5B Q33915290-5D03DDD6-0B3D-45E6-99DF-F55F76A48541 Q33990291-6E63E631-C239-453D-89B9-A3347BC84C99 Q34003280-B25665C0-097C-4665-87C0-5CCCE7749A63 Q34071253-1C1B6033-918C-447E-8380-0B229A320C19 Q34099814-C82B08B6-F546-42C0-9ADB-930F48409885 Q34107573-6F214CEA-2EC1-4CDD-880E-9ED53306520A Q34218639-76420852-1699-4047-82A4-B44D02C8D64F Q34219459-10CCC150-9FAC-4AC6-9717-89A5EA3C87E9 Q34248105-940DE399-CB58-44D7-819F-2156B7CFEB80 Q34249986-42114251-4659-44F9-9E21-EA8C79BA0986 Q34259037-E5982353-3C09-42BB-8ED2-886EDEC8FD0A Q34332252-1AE7A783-4779-4E1D-9567-21B4237950F9 Q34506348-50063D50-DC0E-44BA-BF13-68F0FD401CA1 Q34625182-581FB909-A6A8-4F7D-B054-8F483F5C0D98 Q34681791-EAF0B76C-5470-4F1C-9D29-3030CD5FBDD6 Q34731226-8743C550-E336-4512-8616-3E188D538DAF Q34840428-0A82094C-2192-4A64-A555-406B1E92B7D3 Q35039946-7156EB27-2939-4599-BF08-BF993BD3EF4A Q35060321-7A262C51-3BC6-4439-806C-9A5BF4263849 Q35109173-E957E8D0-3D6E-4D9F-A7E9-A0F0881E64BC Q35112336-42EF3B61-FB45-45D0-8032-22E1534508E6 Q35364243-1D030192-6BD5-4FE2-8C61-2035C6153F2C Q35541858-EC334C61-B20D-4461-9C0A-BEE77D1935C3 Q35548743-16123F67-FD6E-433D-9684-217462CE8BA9 Q35605191-854F1315-6BC7-49FA-8133-127338A99B87 Q35605516-97C61B10-255C-416A-9C93-F0329F79B383

P2860

Interleukin 6 is expressed in high levels in psoriatic skin and stimulates proliferation of cultured human keratinocytes.

http://www.wikidata.org/entity/Q34298307

description

1989 nî lūn-bûn

@nan

1989 թուականի Օգոստոսին հրատարակուած գիտական յօդուած

@hyw

1989 թվականի օգոստոսին հրատարակված գիտական հոդված

@hy

1989年の論文

@ja

1989年論文

@yue

1989年論文

@zh-hant

1989年論文

@zh-hk

1989年論文

@zh-mo

1989年論文

@zh-tw

1989年论文

@wuu

name

Interleukin 6 is expressed in ...... cultured human keratinocytes.

@ast

Interleukin 6 is expressed in ...... cultured human keratinocytes.

@en

Interleukin 6 is expressed in ...... cultured human keratinocytes.

@nl

type

label

Interleukin 6 is expressed in ...... cultured human keratinocytes.

@ast

Interleukin 6 is expressed in ...... cultured human keratinocytes.

@en

Interleukin 6 is expressed in ...... cultured human keratinocytes.

@nl

prefLabel

Interleukin 6 is expressed in ...... cultured human keratinocytes.

@ast

Interleukin 6 is expressed in ...... cultured human keratinocytes.

@en

Interleukin 6 is expressed in ...... cultured human keratinocytes.

@nl

P1433

Q34298307-5E2A7005-9BFA-4E8D-BEA0-D5AC1E26F288

P1476

Q34298307-00A4C9F5-B6B8-4159-AEC1-93200428837B

P2093

Q34298307-10D04C53-55C7-4A01-8194-9EB96D7707F8

Q34298307-24DD43EB-4889-4F9D-BCC7-FBC33D7FDE8B

Q34298307-6DD2DAFD-F7AB-4F7F-B54D-A1B8440396ED

Q34298307-B44BBD4C-400E-40D9-9317-9F41C7E9CEBC

Q34298307-CAC302F6-E323-4157-8C0E-FC36A34C40E9

Q34298307-CE2B5612-8C7B-4EB7-98BE-E013258286D9

Q34298307-D2B22CC2-A4EB-4DBD-8F69-6AF2561C9DBB

Q34298307-E38095CF-8EE2-4DFF-9B7F-4B460E267BFC

Q34298307-F0A3EE9D-CD7C-4912-8921-78EC3F3B645A

P2860

Q34298307-11F79195-56AC-452B-94D8-CD7B161E4914

Q34298307-14846A02-5F5A-4CB0-B6C8-E3980A2718D0

Q34298307-1B7A279E-E060-4073-840A-492AD4374EF4

Q34298307-1F7780B8-56D8-4F4B-97C5-682F6202E29D

Q34298307-3493257B-D518-4F3F-BE64-1922564CF3DD

Q34298307-5CC98803-A461-44F3-B05E-8A036E426FD9

Q34298307-7FFDAAED-7946-455F-B147-3DA53D7B8FA1

Q34298307-81BAF646-23C5-449E-BB03-03FF227A6D40

Q34298307-8CF4A159-D2E7-4DBB-9764-AB1FE470F8C4

Q34298307-96F2B0CC-CEAF-4FE6-9CF3-836F9622831C

P304

Q34298307-4C1F076F-95B7-4EA9-B0D8-E1884E3F1104

P31

Q34298307-86B38278-324F-4C21-B66A-373C57E2EE85

P356

Q34298307-A4AF7A8E-821B-4E34-AFC2-FD0A07741057

P407

Q34298307-262B949E-1E43-43BE-A920-6143501EF1EA

P433

Q34298307-5EA7B892-16A4-4287-964F-2FDFB7220F2F

P478

Q34298307-442DFE67-1B36-494E-9050-87459FD1E404

P577

Q34298307-9B340F6B-A62F-4D18-986B-4836C0E43629

P5875

Q34298307-3A6277FF-61AC-4E95-81B1-B737B28B9576

P698

Q34298307-7CCEFE7E-948D-4011-9A71-6B5B0348F0B8

P921

Q34298307-4c164aa5-5d9f-4bca-914b-950402dabffa

P932

Q34298307-0792B3C7-3782-40BE-8F02-9CFED098A615

P356

PNAS.86.16.6367

P1433

Proceedings of the National Academy of Sciences of the United States of America

P1476

Interleukin 6 is expressed in ...... cultured human keratinocytes.

@en

P2093

A B Gottlieb

http://www.w3.org/2001/XMLSchema#string

A Granelli-Piperno

http://www.w3.org/2001/XMLSchema#string

D P Murphy

http://www.w3.org/2001/XMLSchema#string

D Yourish

http://www.w3.org/2001/XMLSchema#string

J Krueger

http://www.w3.org/2001/XMLSchema#string

L T May

http://www.w3.org/2001/XMLSchema#string

P B Sehgal

http://www.w3.org/2001/XMLSchema#string

R M Grossman

http://www.w3.org/2001/XMLSchema#string

T S Kupper

http://www.w3.org/2001/XMLSchema#string

P2860

Complementary DNA for a novel human interleukin (BSF-2) that induces B lymphocytes to produce immunoglobulin

Activation of the human "beta 2-interferon/hepatocyte-stimulating factor/interleukin 6" promoter by cytokines, viruses, and second messenger agonists.

Influence of delayed immune reactions on human epidermal keratinocytes.

Expression of HLA-DR molecules by keratinocytes, and presence of Langerhans cells in the dermal infiltrate of active psoriatic plaques.

Detection of transforming growth factor alpha in normal, malignant, and hyperproliferative human keratinocytes.

Detection of a gamma interferon-induced protein IP-10 in psoriatic plaques

In situ hybridization for interleukin 2 and interleukin 2 receptor mRNA in T cells activated in the presence or absence of cyclosporin A.

Interleukin 1 and other human keratinocyte cytokines: molecular and functional characterization.

Immunologic mechanisms in psoriasis.

Synthesis and secretion of multiple forms of beta 2-interferon/B-cell differentiation factor 2/hepatocyte-stimulating factor by human fibroblasts and monocytes.

P304

6367-6371

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1073/PNAS.86.16.6367

http://www.w3.org/2001/XMLSchema#string

P407

P433

16

http://www.w3.org/2001/XMLSchema#string

P478

86

http://www.w3.org/2001/XMLSchema#string

P577

1989-08-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

20680971

http://www.w3.org/2001/XMLSchema#string

P698

2474833

http://www.w3.org/2001/XMLSchema#string

P921

P932

297840

http://www.w3.org/2001/XMLSchema#string